|
ZNF766 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.701000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.455800E-01 |
| Normal-vs-Stage2 |
7.989400E-01 |
| Normal-vs-Stage3 |
6.863900E-02 |
| Normal-vs-Stage4 |
2.635400E-01 |
| Stage1-vs-Stage2 |
3.788600E-01 |
| Stage1-vs-Stage3 |
2.036300E-03 |
| Stage1-vs-Stage4 |
4.691600E-02 |
| Stage2-vs-Stage3 |
2.077000E-01 |
| Stage2-vs-Stage4 |
5.065600E-01 |
| Stage3-vs-Stage4 |
5.453000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.351800E-01 |
| Normal-vs-AfricanAmerican |
3.685200E-01 |
| Normal-vs-Asian |
8.275200E-01 |
| Caucasian-vs-AfricanAmerican |
4.187800E-01 |
| Caucasian-vs-Asian |
9.383400E-01 |
| AfricanAmerican-vs-Asian |
8.154600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.998400E-01 |
| Normal-vs-Female |
5.432800E-01 |
| Male-vs-Female |
5.937800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.475600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.785000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.336000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.558370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.483800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.541200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.724200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.263400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.704200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.395610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.103350E-01 |
| Normal-vs-Grade 2 |
3.257000E-01 |
| Normal-vs-Grade 3 |
2.439800E-01 |
| Normal-vs-Grade 4 |
3.784400E-02 |
| Grade 1-vs-Grade 2 |
3.015600E-01 |
| Grade 1-vs-Grade 3 |
5.486100E-02 |
| Grade 1-vs-Grade 4 |
1.961840E-02 |
| Grade 2-vs-Grade 3 |
8.418800E-03 |
| Grade 2-vs-Grade 4 |
1.138760E-03 |
| Grade 3-vs-Grade 4 |
1.800810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.792800E-01 |
| Normal-vs-ccB subtype |
2.756000E-01 |
| ccA subtype-vs-ccB subtype |
9.259800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.548000E-01 |
| Normal-vs-N1 |
9.463900E-02 |
| N0-vs-N1 |
2.389800E-01 |
|
|
